In these guidelines, the panelists propose with caution that in patients with one of the following risk factors Ki67 >30%, large tumour thrombus in the vena cava, Stage IV, or R1 resection, adjuvant chemotherapy should be considered [9]. Here, MKI67 is linked to neoplasm.